Asthma treatment & Asthma control Airsonett –
Asthma clinic assesses for laminar airflow treatment
in the London Allergy and Immunology Centre
Asthma Centre: Asthma assessment, allergy testing, breathing test – spirometry, asthma treatment
Better sleep at night and less asthma symptoms! Asthma treatment in the London Allergy and Immunology Centre
Asthma treatment Airsonett dramatically decreases the concentration of allergens in the breathing zone during night time.
Airsonett asthma treatment means that you sleep breathing clean air and that your immune system thereby will have long and regular periods of recovery.
Research shows that treatment with Airsonett improves sleep at night and decreases the asthma symptoms during the day.
Airsonett improves the allergy, decreases airway inflammation and increase the quality of life1.
This is how Airsonett asthma treatment works
The warm air transports allergens from the bedding towards and through the opening in the blanket. The allergen-rich air then passes the breathing zone (this phenomenon is called body convection). Airsonett displaces the allergen-rich body convection and dramatically decreases the amount of breathed allergens during the night’s sleep. Airsonett is placed beside the bed in your bedroom Airsonett creates filtered, clean air about a half meter above your face. This clean air is slightly cooler than the temperature in the room which results in it slowly descending, pushing away the allergen-rich air. The filtered, clean air which reaches the face creates a virtually allergen free zone, without draft, during the whole of the sleep.
Airsonett has a very low noise level, low energy consumption and is easy to use. After installation in your bedroom, the only thing you need to remember is to use it every night (there is a built-in timer function) and to change the filter every 6 months. The filter will automatically be sent to you well in advance.
1. Boyle RJ, et al. Nocturnal temperature controlled laminar airflow for treating atopic asthma: a randomised controlled trial. Thorax, 2012